Free Trial

Global Medical REIT (NYSE:GMRE) Reaches New 12-Month Low - Here's Why

Global Medical REIT logo with Finance background

Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) hit a new 52-week low on Monday . The company traded as low as $7.13 and last traded at $7.27, with a volume of 604189 shares trading hands. The stock had previously closed at $7.73.

Wall Street Analysts Forecast Growth

Separately, B. Riley assumed coverage on shares of Global Medical REIT in a research report on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 target price for the company.

Read Our Latest Stock Report on GMRE

Global Medical REIT Price Performance

The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The company has a 50 day moving average of $8.31 and a two-hundred day moving average of $8.50. The firm has a market cap of $466.43 million, a P/E ratio of -348.58, a PEG ratio of 1.43 and a beta of 1.12.

Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.21. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The company had revenue of $35.16 million for the quarter, compared to analysts' expectations of $34.87 million. Sell-side analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current year.

Global Medical REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 9th. Stockholders of record on Friday, March 21st were given a dividend of $0.21 per share. The ex-dividend date was Friday, March 21st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 12.04%. Global Medical REIT's dividend payout ratio (DPR) is presently 8,400.00%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in GMRE. Man Group plc grew its stake in Global Medical REIT by 321.7% during the 4th quarter. Man Group plc now owns 561,022 shares of the company's stock valued at $4,331,000 after acquiring an additional 427,987 shares in the last quarter. Balyasny Asset Management L.P. acquired a new stake in shares of Global Medical REIT during the fourth quarter worth approximately $2,904,000. JPMorgan Chase & Co. grew its position in Global Medical REIT by 94.5% during the fourth quarter. JPMorgan Chase & Co. now owns 451,197 shares of the company's stock valued at $3,483,000 after purchasing an additional 219,270 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Global Medical REIT in the 4th quarter valued at approximately $1,430,000. Finally, Pacific Ridge Capital Partners LLC lifted its position in Global Medical REIT by 31.9% in the 4th quarter. Pacific Ridge Capital Partners LLC now owns 712,101 shares of the company's stock worth $5,497,000 after buying an additional 172,171 shares in the last quarter. 57.52% of the stock is currently owned by institutional investors and hedge funds.

Global Medical REIT Company Profile

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Stories

Should You Invest $1,000 in Global Medical REIT Right Now?

Before you consider Global Medical REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.

While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines